학술논문
P1.01-004 Hypertension With Brigatinib: Experience in ALTA, a Randomized Phase 2 Trial in Crizotinib-Refractory ALK+ NSCLC
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1893-S1893
Subject
Language
ISSN
1556-0864